Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2004 Apr 06;10114:4833-8. doi: 10.1073/pnas.0401028101.
Show Gene links
Show Anatomy links
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.
Wang S
,
Ai X
,
Freeman SD
,
Pownall ME
,
Lu Q
,
Kessler DS
,
Emerson CP
.
???displayArticle.abstract???
The signaling activities of multiple developmental ligands require sulfated heparan sulfate (HS) proteoglycans as coreceptors. QSulf1 and its mammalian orthologs are cell surface HS 6-O-endosulfatases that are expressed in embryonic mesodermal and neural progenitors and promote Wnt signal transduction. In this study, we have investigated the function of QSulf1 in fibroblast growth factor (FGF) signaling, which requires 6-O-sulfated HS for FGF receptor (FGFR) dimerization and tyrosine kinase activation. Here, we report that QSulf1 inhibits FGF2- and FGF4-induced mesoderm formation in the Xenopus embryo and FGF-dependent angiogenesis in the chicken embryo through 6-O-desulfation of cell surface HS. QSulf1 regulates FGF signaling through inhibition of HS-mediated FGFR1 activation by interfering with FGF-HS-FGFR1 ternary complex formation. Furthermore, QSulf1 can produce enzymatically modified soluble heparin that acts as a potent inhibitor of FGF2-induced angiogenesis in the chicken embryo. QSulf1, therefore, has dual regulatory functions as a negative regulator of FGF signaling and a positive regulator of Wnt signaling. Therefore, QSulf1 provides another reagent to produce enzymatically modified heparin compounds, in vivo and in vitro, to modulate cellular signaling in stem cell-based therapies to promote tissue regeneration and in cancer therapies to control cell growth and block angiogenesis.
Ai,
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
2003, Pubmed
Ai,
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
2003,
Pubmed
Allen,
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
2001,
Pubmed
Bullock,
Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase.
1998,
Pubmed
,
Xenbase
Dhoot,
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase.
2001,
Pubmed
Engleka,
VegT activation of Sox17 at the midblastula transition alters the response to nodal signals in the vegetal endoderm domain.
2001,
Pubmed
,
Xenbase
Esko,
Molecular diversity of heparan sulfate.
2001,
Pubmed
Fannon,
Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
2000,
Pubmed
Folkman,
Role of angiogenesis in tumor growth and metastasis.
2002,
Pubmed
Friedlander,
Definition of two angiogenic pathways by distinct alpha v integrins.
1995,
Pubmed
Irie,
Heparan sulfate is required for bone morphogenetic protein-7 signaling.
2003,
Pubmed
Isaacs,
Expression of a novel FGF in the Xenopus embryo. A new candidate inducing factor for mesoderm formation and anteroposterior specification.
1992,
Pubmed
,
Xenbase
Izvolsky,
Heparan sulfate-FGF10 interactions during lung morphogenesis.
2003,
Pubmed
Jemth,
Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.
2002,
Pubmed
Kamimura,
Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.
2001,
Pubmed
Kresse,
Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
1980,
Pubmed
Lai,
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
2003,
Pubmed
Lin,
Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling.
1999,
Pubmed
Lundin,
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
2000,
Pubmed
Lüders,
Slalom encodes an adenosine 3'-phosphate 5'-phosphosulfate transporter essential for development in Drosophila.
2003,
Pubmed
Merry,
The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse.
2001,
Pubmed
Morimoto-Tomita,
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.
2002,
Pubmed
Neilson,
Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains.
1996,
Pubmed
,
Xenbase
Nybakken,
Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila.
2002,
Pubmed
Ohto,
Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage.
2002,
Pubmed
Ornitz,
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.
1992,
Pubmed
Ornitz,
Fibroblast growth factors.
2001,
Pubmed
Pellegrini,
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
2000,
Pubmed
Plotnikov,
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
2000,
Pubmed
Pownall,
An inducible system for the study of FGF signalling in early amphibian development.
2003,
Pubmed
,
Xenbase
Pye,
Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.
1998,
Pubmed
Rapraeger,
Heparan sulfate-growth factor interactions.
2002,
Pubmed
Reichsman,
Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction.
1996,
Pubmed
Roghani,
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.
1994,
Pubmed
Sasisekharan,
Roles of heparan-sulphate glycosaminoglycans in cancer.
2002,
Pubmed
Schlessinger,
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
2000,
Pubmed
Slack,
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors.
,
Pubmed
,
Xenbase
Toyoda,
Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes.
2000,
Pubmed
Wu,
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
2003,
Pubmed
Yao,
Mesoderm induction in Xenopus. Oocyte expression system and animal cap assay.
2000,
Pubmed
,
Xenbase
Yayon,
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
1991,
Pubmed
